553
Views
42
CrossRef citations to date
0
Altmetric
Articles

The Textures of Heroin: User Perspectives on “Black Tar” and Powder Heroin in Two U.S. Cities

, Ph.D., , Ph.D., , B.A., M.D./Ph.D. Candidate, , M.Phil., Ph.D. Candidate & , M.D., M.P.H.
Pages 270-278 | Received 03 Nov 2015, Accepted 16 May 2016, Published online: 20 Jul 2016

References

  • Akhgari, M., F. Jokar, L. Bahmanabadi, and A. E. Aleagha. 2012. Street-level heroin seizures in Iran: A survey of components. Journal of Substance Use 17 (4):348–55. doi:10.3109/14659891.2011.592898.
  • Bancroft, A., and P. S. Reid. 2015. Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge. International Journal of Drug Policy, Online pre-publication. doi:10.1016/j.drugpo.2015.11.008.
  • Bardenheier, B., D. R. Prevots, N. Khetsuriani, and M. Wharton. 1998. Tetanus surveillance–United States, 1995–1997. MMWR CDC Surveill Summ 47 (2):1–13.
  • Binswanger, I. A., A. H. Kral, R. N. Bluthenthal, D. J. Rybold, and B. R. Edlin. 2000. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical Infectious Diseases 30 (3):579–81. doi:10.1086/313703.
  • Bourgois, P. 1998. The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use & Misuse 33 (11):2323–51. doi:10.3109/10826089809056260.
  • Bourgois, P., B. Prince, and A. Moss. 2004. The everyday violence of Hepatitis C among young women who inject drugs in San Francisco. Human Organization 63 (3):253–64. doi:10.17730/humo.63.3.h1phxbhrb7m4mlv0.
  • Bourgois, P., and J. Schonberg. 2009. Righteous dope fiend. Berkeley, CA: University of California Press.
  • Ciccarone, D. 2005. The political economy of heroin: Regional markets, practices and consequences. International Journal of Drug Policy 16 (5):289–90. doi:10.1016/j.drugpo.2005.06.001.
  • Ciccarone, D. 2009. Heroin in brown, black and white: Structural factors and medical consequences in the U.S. heroin market. International Journal of Drug Policy 20 (3):277–82. doi:10.1016/j.drugpo.2008.08.003.
  • Ciccarone, D., J. Bamberger, A. Kral, C. J. Hobart, A. Moon, B. R. Edlin, H. W. Harris, D. M. Young, P. Bourgois, and E. L. Murphy. 2001. Soft tissue infections among injection drug users: San Francisco, California, 1996–2000. Journal of the American Medical Association 285 (21):2707–09.
  • Ciccarone, D., and P. Bourgois. 2003. Explaining the geographical variation of HIV among injection drug users in the United States. Substance Use & Misuse 38 (14):2049–63. doi:10.1081/JA-120025125.
  • Ciccarone, D., and M. Harris. 2015. Fire in the vein: Heroin acidity and its proximal effect on users’ health. International Journal of Drug Policy 26 (11):1103–10. doi:10.1016/j.drugpo.2015.04.009.
  • Ciccarone, D., G. J. Unick, J. Cohen, S. Mars., and D. Rosenblum. 2016. Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions. Drug and Alcohol Dependence 163:126–33. doi:10.1016/j.drugalcdep.2016.04.009.
  • DEA (Drug Enforcement Administration). 2015a. National heroin threat assessment summary. In DEA intelligence report. Available at: https://www.dea.gov/divisions/hq/2015/hq052215_National_Heroin_Threat_Assessment_Summary.pdf
  • DEA (Drug Enforcement Administration). 2015b. National forensic laboratory information system special report: Opiates and related drugs reported in NFLIS, 2009–2014. Springfield, VA: US Drug Enforcement Administration, Office of Diversion Control.
  • Epele, M. E. 2002. Scars, harm and pain: About being injected among drug using Latina Women. Journal of Ethnicity in Substance Abuse 1 (1):47–69. doi:10.1300/J233v01n01_04.
  • Harris, H. W., and D. M. Young. 2002. Care of injection drug users with soft tissue infections in San Francisco, California. Archives of Surgery 137 (11):1217–22. doi:10.1001/archsurg.137.11.1217.
  • Hempstead, K., and E. O. Yildirim. 2014. Supply-side response to declining heroin purity: Fentanyl overdose episode in New Jersey. Health Economics 23 (6):688–705. doi:10.1002/hec.2937.
  • Kimura, A. C., J. I. Higa, R. M. Levin, G. Simpson, Y. Vargas, and D. J. Vugia. 2004. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clinical Infectious Diseases 38 (9):e87–91. doi:10.1086/383471.
  • Mackun, P., and S. Wilson. 2011. Population distribution and change: 2000 to 2010, US census briefs. Washington, DC: US Census Bureau.
  • Maher, W., M. Swift, and L. Dawson. 2001. Heroin purity and composition in Sydney, Australia. Drug and Alcohol Review 20 (4):439–48. doi:10.1080/09595230120092698.
  • Mars, S., P. Bourgois, G. Karandinos, F. Montero, and D. Ciccarone. 2014. Every “Never” I ever said came true: Pathways from pills to heroin injecting. International Journal of Drug Policy 25 (2):257–66. doi:10.1016/j.drugpo.2013.10.004.
  • Mars, S., J. N. Fessel, P. Bourgois, G. Karandinos, F. Montero, and D. Ciccarone. 2015. Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United States. Social Science & Medicine 140:44–53. doi:10.1016/j.socscimed.2015.06.032.
  • Mauss, M. 1924. The gift: The form and reason for exchange in archaic societies. Translated by W. Halls. London, UK: Routledge. Original edition, 1924. Reprint, 1990.
  • Murphy, E. L., D. DeVita, H. Liu, E. Vittinghoff, P. Leung, D. H. Ciccarone, and B. R. Edlin. 2001. Risk factors for skin and soft-tissue abscesses among injection drug users: A case-control study. Clinical Infectious Diseases 33 (1):35–40. doi:10.1086/320879.
  • NVivo. 2012. NVivo 10 qualitative data analysis software. Doncaster, Australia: QSR International Ltd.
  • ONDCP, Office of National Drug Control Policy. 2012. Drug availability estimates in the United States, 2001–2006. Washington, DC: ONDCP.
  • Passaro, D. J., S. B. Werner, J. McGee, W. R. Mac Kenzie, and D. J. Vugia. 1998. Wound botulism associated with black tar heroin among injecting drug users. Jama 279 (11):859–63. doi:10.1001/jama.279.11.859.
  • Rhodes, T. 2009. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy 20 (3):193–201. doi:10.1016/j.drugpo.2008.10.003.
  • Rich, J. D., B. P. Dickinson, J. M. Carney, A. Fisher, and R. Heimer. 1998. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 12 (17):2345–50. doi:10.1097/00002030-199817000-00017.
  • Rosenblum, D., F. Montero, P. Bourgois, S. Mars, G. Karandinos, G. Unick, and D. Ciccarone. 2013. Urban segregation and the U.S. heroin market: A quantitative model of anthropological hypotheses from an inner-city drug market. International Journal of Drug Policy (Special Issue: Place Matters: Drug Users’ Health and Drug Policy):S0955–3959. doi:10.1016/j.drugpo.2013.12.008.
  • Rosenblum, D., G. Unick, and D. Ciccarone. 2014. The entry of Colombian-sourced heroin into the U.S. market: The relationship between competition, price, and purity. International Journal of Drug Policy 25 (1):88–95. doi:10.1016/j.drugpo.2013.10.003.
  • Strang, J., P. Griffiths, and M. Gossop. 1997. Heroin in the United Kingdom: Different forms, different origins, and the relationship to different routes of administration. Drug and Alcohol Review 16 (4):329–37. doi:10.1080/09595239700186711.
  • Strauss, A. L., and J. M. Corbin. 1990. Basics of qualitative research: Grounded theory procedures and techniques. Newbury Park, CA: Sage Publications.
  • Unick, G., D. Rosenblum, S. Mars, and D. Ciccarone. 2014. The relationship between U.S. heroin market dynamics and heroin-related overdose, 1992–2008. Addiction 109 (11):1889–98. doi:10.1111/add.12664.
  • Werner, S. B., D. Passaro, J. McGee, R. Schechter, and D. J. Vugia. 2000. Wound botulism in California, 1951–1998: Recent epidemic in heroin injectors. Clinical Infectious Diseases 31 (4):1018–24. doi:10.1086/318134.
  • Williamson, N., C. Archibald, and J. S. Van Vliet. 2001. Unexplained deaths among injection drug users: A case of probable Clostridium myonecrosis. CMAJ 165 (5):609–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.